Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ESPIDIFEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

ESPIDIFEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Zambon S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 29, 2025
Approval ID: 2d863a34e116202e
Company: Zambon S.A.U.
Type: Standard

Approval Details

Approval Id: 2d863a34e116202e
Drug Cima Aemps Name: ESPIDIFEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 90723
Holder Company Name: Zambon S.A.U.
Marketing Company Name: Zambon S.A.U.
Authorization Date: 2025-10-29
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 600 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Zambon S.A.U.

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 29, 2025

Approval ID

2d863a34e116202e

Type

Standard

Back to CIMA-AEMPS Approvals

ESPIDIFEN 600 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details